265 related articles for article (PubMed ID: 7931664)
1. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis PJ; Salama A
J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
Alavi A; Buchpiguel CA; Loessner A
J Nucl Med; 1994 Oct; 35(10):1650-2. PubMed ID: 7931665
[No Abstract] [Full Text] [Related]
3. Cancer or inflammation? A Holy Grail for nuclear medicine.
Larson SM
J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
[No Abstract] [Full Text] [Related]
4. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
6. FDG PET in the clinical evaluation of sarcoidosis with bone lesions.
Kobayashi A; Shinozaki T; Shinjyo Y; Kato K; Oriuchi N; Watanabe H; Takagishi K
Ann Nucl Med; 2000 Aug; 14(4):311-3. PubMed ID: 11023033
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
8. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
Yasuda S; Shohtsu A; Ide M; Takagi S; Ogawa J; Mitomi T; Suzuki Y
Clin Nucl Med; 1996 Dec; 21(12):983-4. PubMed ID: 8957624
[No Abstract] [Full Text] [Related]
9. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
10. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Li YJ; Zhang Y; Gao S; Bai RJ
Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
[No Abstract] [Full Text] [Related]
11. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
12. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC
J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
[TBL] [Abstract][Full Text] [Related]
13. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET appearance of pelvic Castleman's disease.
Murphy SP; Nathan MA; Karwal MW
J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
16. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
17. The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of Milan.
Crippa F; Agresti R; Donne VD; Pascali C; Bogni A; Chiesa C; De Sanctis V; Schiavini M; Decise D; Bombardieri E
Tumori; 1997; 83(2):542-3. PubMed ID: 9226015
[No Abstract] [Full Text] [Related]
18. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Iino M; Iizuka C
Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
[TBL] [Abstract][Full Text] [Related]
19. Lymph node uptake of 18F-fluorodeoxyglucose detected with positron emission tomography/computed tomography mimicking malignant lymphoma in a patient with Kikuchi disease.
Zhang MJ; Xiao L; Zhu YH; Jiang JJ; Jiang MS; He W
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):477-9. PubMed ID: 21156466
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose.
Kubota K; Yamada K; Yoshioka S; Yamada S; Ito M; Ido T
Clin Nucl Med; 1992 May; 17(5):361-3. PubMed ID: 1587040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
